Effects of cantharidinimides on human carcinoma cells

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 7, 2004, Pages 855-857

  Lin, Lun Huei ^a   Huang, Hsu Shan ^b   Lin, Chiung Chang ^a   Lee, Lin Wen ^c   Lin, Pen Yuan ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cantharidin; Cantharidinimide; HepG2; HL 60

Indexed keywords

3,4 DIETHYLENOXYPHENYLCANTHARIDINIMIDE; ANTINEOPLASTIC AGENT; BENZENE DERIVATIVE; CANTHARIDIN; CYCLOPROPYLCANTHARIDINIMIDE; IMIDE; N (4 BIPHENYL)CANTHARIDINIMIDE; N (4 HYDROXYPHENYL)CANTHARIDINIMIDE; N 3 (1 HYDROXY)PHENYLCANTHARIDINIMIDE; N 4 (1 NITRO)PHENYLCANTHARIDINIMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL STRAIN HEPG2; CELL STRAIN HL 60; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; STRUCTURE ANALYSIS; ANIMAL; BEETLE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BEETLES; CANTHARIDIN; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; IMIDES;

EID: 16544383375     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.52.855     Document Type: Article

References (15)

1. Lin P. Y., Shi S. J., Hsu F. L., Chen C. F., J. Chin. Chem. Soc., 45, 323-236 (1998).
2. Lin P. Y., Shi S. J., Shu H. L, Chen H. F., Lin C. C., Liu P. C., Wang L. F., Bioorg. Chem., 28, 266-272 (2000).
3. Lin P. Y., Shi S. J., Lin L. H., Chen H. F., Hsu F. L., J. Chin. Chem. Soc., 48, 49-53 (2001).
4. Wang G.. S., J. Ethnopharmacol., 26, 147-162 (1989).
5. Neumann J., Herzig S., Boknik P., Apel M., Kaspareit G.., Schmitz W., Scholz H., Tepel M., Zimmermann N., J. Pharmacol. Exp. Ther., 274, 530-539 (1995).
6. Carrel J. E., Mccairel M. H., Doom J. P., Experimentia, 49, 171-175 (1993).
7. Fillmore K., Bagatell K., Dugan B. S., J. Invest. Dermatol., 47, 606-611 (1966).
8. Yell J. A., Buge S. M., Dean D., Br. J. Dermatol., 131, 40-46 (1994).
9. Decker R. H., J. Invest. Dermatol., 42, 465-471 (1963).
10. Li Y. M., Casida J. E., Proc. Natl. Acad. Sci. U.S.A., 89, 11867-11870 (1992).
11. Honkane R. E., FEBS Lett., 330, 283-285 (1993).
12. Graziano M. J., Waterhouse A. L., Casida J. E., Biochem. Biophys. Res. Commun., 149, 79-81 (1987).
13. Tsauer W., Lin J. G., Lin P. Y., Hsu. F. L., Chiang H. C., Anticancer Res., 17, 2095-2098 (1997).
14. Twentyman P. R., Lusccombe M., Br. J. Cancer, 56, 279-284 (1987).
15. van de Loosdrecht A. A., Beelen R. H., Ossenkoppele G. J., Broekhoven M. G., Langenhuijsen M. M., J. Immunol. Methods, 174, 311-320 (1994).